These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 29691115)

  • 1. Beyond total mesorectal excision in locally advanced rectal cancer with organ or pelvic side-wall involvement.
    Mariathasan AB; Boye K; Giercksky KE; Brennhovd B; Gullestad HP; Emblemsvåg HL; Grøholt KK; Dueland S; Flatmark K; Larsen SG
    Eur J Surg Oncol; 2018 Aug; 44(8):1226-1232. PubMed ID: 29691115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Robotic-assisted resection for beyond TME rectal cancer: a novel classification and analysis from a specialized center.
    Piozzi GN; Lee TH; Kwak JM; Kim J; Kim SH
    Updates Surg; 2021 Jun; 73(3):1103-1114. PubMed ID: 33068271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Robotic beyond total mesorectal excision for locally advanced rectal cancers: Perioperative and oncological outcomes from a multicentre case series.
    Khan JS; Piozzi GN; Rouanet P; Saklani A; Ozben V; Neary P; Coyne P; Kim SH; Garcia-Aguilar J
    Eur J Surg Oncol; 2024 Jun; 50(6):108308. PubMed ID: 38583214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Surgery for locally recurrent rectal cancer in the era of total mesorectal excision: is there still a chance for cure?
    Rahbari NN; Ulrich AB; Bruckner T; Münter M; Nickles A; Contin P; Löffler T; Reissfelder C; Koch M; Büchler MW; Weitz J
    Ann Surg; 2011 Mar; 253(3):522-33. PubMed ID: 21209587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design.
    Denost Q; Saillour F; Masya L; Martinaud HM; Guillon S; Kret M; Rullier E; Quintard B; Solomon M
    BMC Cancer; 2016 Apr; 16():262. PubMed ID: 27044252
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Comparison of long-term efficacy between watch and wait strategy and total mesorectal excision in locally advanced rectal cancer patients with clinical complete response after neoadjuvant therapy].
    Wang XH; Zhou CJ; Zhang S; Wang QX; Xiao WW; Ding PR; Chen G; Pan ZZ; Zeng ZF; Gao YH
    Zhonghua Wei Chang Wai Ke Za Zhi; 2020 Mar; 23(3):266-273. PubMed ID: 32192306
    [No Abstract]   [Full Text] [Related]  

  • 8. Beyond transanal total mesorectal excision: short-term outcomes of transanal total mesorectal excision in locally advanced rectal cancer requiring resection beyond total mesorectal excision.
    Larach JT; Rajkomar AKS; Smart PJ; McCormick JJ; Heriot AG; Warrier SK
    Colorectal Dis; 2021 Apr; 23(4):823-833. PubMed ID: 33217140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extended Total Mesorectal Excision (e-TME) for Locally Advanced Rectal Cancer.
    Pandit N; Deo KB; Gautam S; Yadav TN; Kafle A; Singh SK; Awale L
    J Gastrointest Cancer; 2022 Jun; 53(2):253-258. PubMed ID: 33417198
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Long-Term Outcome of Rectal Cancer With Clinically (EUS/MRI) Metastatic Mesorectal Lymph Nodes Treated by Neoadjuvant Chemoradiation: Role of Organ Preservation Strategies in Relation to Pathologic Response.
    Belluco C; Forlin M; Olivieri M; Cannizzaro R; Canzonieri V; Buonadonna A; Bidoli E; Matrone F; Bertola G; De Paoli A
    Ann Surg Oncol; 2016 Dec; 23(13):4302-4309. PubMed ID: 27489059
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualizing surgical treatment based on tumour response following neoadjuvant therapy in T4 primary rectal cancer.
    Denost Q; Kontovounisios C; Rasheed S; Chevalier R; Brasio R; Capdepont M; Rullier E; Tekkis PP
    Eur J Surg Oncol; 2017 Jan; 43(1):92-99. PubMed ID: 27717529
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic factors and patterns of failure after surgery for T4 rectal cancer in the beyond total mesorectal excision era.
    Peacock O; Waters PS; Bressel M; Lynch AC; Wakeman C; Eglinton T; Koh CE; Lee PJ; Austin KK; Warrier SK; Solomon MJ; Frizelle FA; Heriot AG
    Br J Surg; 2019 Nov; 106(12):1685-1696. PubMed ID: 31339561
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Near-infrared laparoscopic fluorescence for pelvic side wall delta mapping in patients with rectal cancer--'PINPOINT' nodal assessment.
    Kazanowski M; Al Furajii H; Cahill RA
    Colorectal Dis; 2015 Oct; 17 Suppl 3():32-5. PubMed ID: 26394741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Techniques and Outcome of Surgery for Locally Advanced and Local Recurrent Rectal Cancer.
    Renehan AG
    Clin Oncol (R Coll Radiol); 2016 Feb; 28(2):103-115. PubMed ID: 26683258
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Short-term results after robot-assisted surgery for primary rectal cancers requiring beyond total mesorectal excision in multiple compartments.
    Thorgersen EB; Solbakken AM; Strøm TK; Goscinski M; Spasojevic M; Larsen SG; Flatmark K
    Scand J Surg; 2024 Mar; 113(1):3-12. PubMed ID: 37787437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efforts to improve local control in rectal cancer compromise survival by the potential morbidity of optimal mesorectal excision.
    Laurent C; Nobili S; Rullier A; Vendrely V; Saric J; Rullier E
    J Am Coll Surg; 2006 Nov; 203(5):684-91. PubMed ID: 17084330
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Laparoscopic total mesorectal excision (TME) for rectal cancer surgery: long-term outcomes.
    Leroy J; Jamali F; Forbes L; Smith M; Rubino F; Mutter D; Marescaux J
    Surg Endosc; 2004 Feb; 18(2):281-9. PubMed ID: 14691716
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Magnetic resonance-based pelvimetry and tumor volumetry can predict surgical difficulty and oncologic outcome in locally advanced mid-low rectal cancer.
    Atasoy G; Arslan NC; Elibol FD; Sagol O; Obuz F; Sokmen S
    Surg Today; 2018 Dec; 48(12):1040-1051. PubMed ID: 29961173
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oncological outcomes after total mesorectal excision for cure for cancer of the lower rectum: anterior vs. abdominoperineal resection.
    Wibe A; Syse A; Andersen E; Tretli S; Myrvold HE; Søreide O;
    Dis Colon Rectum; 2004 Jan; 47(1):48-58. PubMed ID: 14719151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: A multicentric phase II study.
    Valentini V; Morganti AG; Gambacorta MA; Mohiuddin M; Doglietto GB; Coco C; De Paoli A; Rossi C; Di Russo A; Valvo F; Bolzicco G; Dalla Palma M;
    Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1129-39. PubMed ID: 16414206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.